agilon health (NYSE:AGL) Price Target Raised to $3.15 at Sanford C. Bernstein

agilon health (NYSE:AGL) had its target price boosted by Sanford C. Bernstein from $2.50 to $3.15 in a research report released on Wednesday morning,Benzinga reports. Sanford C. Bernstein currently has a market perform rating on the stock.

Several other research analysts also recently issued reports on the company. Macquarie initiated coverage on agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective for the company. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Needham & Company LLC initiated coverage on shares of agilon health in a research report on Friday, January 10th. They set a “hold” rating for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price target on shares of agilon health in a research report on Tuesday, November 19th. Finally, TD Cowen lowered their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Two analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $4.03.

agilon health Stock Up 1.1 %

agilon health stock opened at $2.85 on Wednesday. The company’s 50 day simple moving average is $2.07 and its 200 day simple moving average is $3.68. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -3.03 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. As a group, sell-side analysts anticipate that agilon health will post -0.59 EPS for the current year.

Insiders Place Their Bets

In other news, Director Diana Mckenzie bought 12,500 shares of the business’s stock in a transaction on Monday, November 25th. The stock was acquired at an average price of $2.28 per share, with a total value of $28,500.00. Following the completion of the purchase, the director now directly owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 90,000 shares of company stock valued at $198,100 over the last quarter. 3.20% of the stock is owned by corporate insiders.

Institutional Trading of agilon health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Oak Thistle LLC bought a new stake in agilon health in the fourth quarter valued at approximately $25,000. Pines Wealth Management LLC bought a new stake in agilon health in the fourth quarter valued at approximately $51,000. JPMorgan Chase & Co. lifted its position in agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Virtu Financial LLC bought a new position in shares of agilon health during the third quarter valued at approximately $120,000. Finally, Geode Capital Management LLC raised its holdings in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after acquiring an additional 84,889 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.